Palmoplantar cutaneous reaction secondary to sorafenib;Reacción cutánea palmo-plantar secundaria a sorafenib

Actas Dermo-Sifiliograficas

Volumn 100, Issue 8, 2009, Pages 736-737

  Echeverria B ^a   Llombart, B ^a   Botella Estrada, R ^a   Guillen C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; ORAL ANTIDIABETIC AGENT; SORAFENIB;

ADULT; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DRUG WITHDRAWAL; ERYTHEMA; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; LETTER; MALE; SKIN BIOPSY; SKIN MANIFESTATION; TOPICAL TREATMENT;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; DRUG ERUPTIONS; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; PYRIDINES; SKIN DISEASES, VESICULOBULLOUS;

EID: 70350764787     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(09)72296-3     Document Type: Letter

References (7)

1. J. Autier, B. Escudier, J. Wechsler, A. Spatz, and C. Robert Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinasa inhibitor Arch Dermatol 144 2008 886 892
2. C. Robert, C. Mateus, A. Spatz, J. Wechsler, and B. Escudier Dermatologic symptoms associated with the multikinase inhibitor sorafenib J Am Acad Dermatol 60 2009 299 305
3. L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, and D. Wilkie et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res 66 2006 11851 11858
4. C. Robert, C. Mateus, A. Spatz, J. Wechsler, and B. Escudier Dermatologic symptoms associated with the multikinase inhibitor sorafenib J Am Acad Dermatol 60 2009 299 305
5. L. Hueso, O. Sanmartín, E. Nagore, R. Botella-Estrada, C. Re quena, and B. Llombart et al. Eritema acral inducido por quimioterapia: estudio clínico e histopatológico de 44 casos Actas Dermosifiliogr 99 2008 281 290
6. E. Nagore, A. Insa, and O. Sanmartín Antineoplastic therapy-induced palmo plantar erythrodysesthesia («hand-foot») syndrome. Incidence, recognition and management Am J Clin Dermatol 1 2000 225 234
7. C.H. Yang, W.C. Lin, C.K. Chuang, Y.C. Chang, S.T. Pang, and Y.C. Lin et al. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinasa inhibitor therapy Br J Dermatol 158 2008 592 596